Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
about
Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s LymphomaHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsThe rising challenge of non-AIDS-defining cancers in HIV-infected patientsThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careEpstein-Barr virus and the origin of Hodgkin lymphomaEpidemic of lung cancer in patients with HIV infectionEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionA Review of Management of Inflammation in the HIV PopulationEurogin 2016 Roadmap: how HPV knowledge is changing screening practice.DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.Lung cancer in HIV patients and their parents: a Danish cohort study.The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in JapanRecent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.Neurocognitive effects of HIV, hepatitis C, and substance use historyProtein adducts as prospective biomarkers of nevirapine toxicity.Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.Non-AIDS-Defining Malignancies in the HIV-Infected PopulationContinuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyChanging patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.Hodgkin's Disease in Patients with HIV InfectionMeningeal Hemangiopericytoma with Intracranial Metastases in an HIV-Positive Male: Case Report and Review of the Literature.Reduced risk of prostate cancer in U.S. Men with AIDS.Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007HIV-associated anal cancer.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.Cancer biomarkers in HIV patientsCharacteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.Cancer burden in the HIV-infected population in the United StatesManagement of HIV infection in patients with cancer receiving chemotherapy.Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphomaNon-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.Breast Cancer in the Setting of HIVContribution of HIV infection to mortality among cancer patients in Uganda.Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysisSquamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexualsHIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies.Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
P2860
Q24240190-BB66BF79-E970-45B7-8EBB-42245198D22FQ26740117-2587F5C7-BCBA-4AE7-89CF-F287FFDC5EBDQ26861496-44D2D15E-D0AF-4AB6-A1F5-65130F1A46E6Q26991549-BB5F7C31-85C5-4E62-8F0D-354E4AD913E0Q26998999-9AB66BF7-3F11-4C9C-8D17-5AFF144DB18EQ27000028-497B8CB1-3FD5-49FD-A98C-D23ED008A639Q27022706-C0B28952-8CF6-4889-9B68-867B140FE058Q28078962-B00DA34D-7C96-4258-9F63-FB86CA193D77Q30239987-67440DF1-EBF2-4AA9-8952-A5ED62DF37F5Q30408029-4E4E7EBE-D8DA-47A9-BDBA-556FECC02AC9Q30491585-872967AB-2737-4859-AC8C-1BC6E86C4F0AQ31021219-9CB78747-08EE-46F3-B04E-C3BB89F39489Q33593774-1BB7861E-2002-4878-A882-60A2299254D5Q33633451-9EDA9D93-8007-49E2-BC7B-C06661619FAFQ33652957-AE0844BC-EC4B-48FC-80CF-965C3595A5ADQ33681307-579684F7-E233-42D1-8E08-EE9D16E9A868Q33696149-5BB6B130-494B-46DD-A444-E13A253296C6Q33734376-FE019207-1C32-4124-87F0-52070BED5388Q33859370-15BAC978-2269-46CC-811A-441CB1E62D3DQ33863292-56ADBC1D-F999-4CB4-9389-66C7F5963345Q34059657-5E8B3CD8-420D-46C7-ABBC-4AB8243AB19BQ34169941-4E6E6DDD-BEF6-4422-8D9F-762593A5966EQ34292313-0F130370-B9EF-4075-A165-E9FB85720A36Q34292990-74237071-6E1B-4E58-851A-46DA9228C263Q34348772-F23DBBF0-2133-496A-A7A8-8FBCEB779AC0Q34519280-16CF57B5-675B-4EB5-A467-21F8107ED8ABQ34612071-90482C5C-DAFE-4F80-A489-8671714D80F1Q34661370-29FAE6D7-8FA6-49CE-BA29-C38A02FD43F0Q34774173-811AF5A7-8DF3-42B4-9786-228571EDD47FQ34916327-8F4BC1B7-79EE-4953-919D-077B7023148DQ35008342-B0CDA74A-5320-4DE9-BC66-023C203AFBA6Q35009761-1B26B28D-1E80-44B5-B0AA-D6AFB166B38CQ35012513-875E28B7-FDC9-474C-8FFA-06C8B6DBF617Q35026128-DBD11C86-F951-420C-8CED-A61363FB6161Q35056551-443F7887-DB7C-4FCE-B62B-CCDAD090F315Q35063571-FCC95B43-619A-4EB0-B046-4DD295048CFAQ35093611-A53E98DF-8B21-4303-A881-E772A879368CQ35114512-1C409835-34C7-4385-A181-05841640CDB2Q35150769-819AFE17-B419-42D6-8F8C-354BE915B7A8Q35233148-52CCEB10-847A-4D9F-9D54-80358B36E38F
P2860
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Highly active antiretroviral t ...... in people with HIV infection.
@ast
Highly active antiretroviral t ...... in people with HIV infection.
@en
Highly active antiretroviral t ...... in people with HIV infection.
@nl
type
label
Highly active antiretroviral t ...... in people with HIV infection.
@ast
Highly active antiretroviral t ...... in people with HIV infection.
@en
Highly active antiretroviral t ...... in people with HIV infection.
@nl
prefLabel
Highly active antiretroviral t ...... in people with HIV infection.
@ast
Highly active antiretroviral t ...... in people with HIV infection.
@en
Highly active antiretroviral t ...... in people with HIV infection.
@nl
P2093
P356
P1476
Highly active antiretroviral t ...... s in people with HIV infection
@en
P2093
Brian Gazzard
David Robinson
Jonathan Shamash
Justin Stebbing
Mark Nelson
Sundhiya Mandelia
Thomas Powles
P304
P356
10.1200/JCO.2008.19.6626
P407
P577
2008-12-29T00:00:00Z